Stay updated with breaking news from Paediatric trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Author summary Why was this study done? ➢ Clinicians and researchers depend on the peer-reviewed literature for accurate assessments of drug efficacy and safety, but this depends on whether the outcomes of all trials—negative, as well as positive—are reported transparently. ➢ In an earlier study, using Food and Drug Administration (FDA) review documents as a gold standard, we found that many negative trials had been misreported in the published literature as having positive outcomes or had simply not been published. ➢ Since then, reporting bias has been the subject of additional studies and policy changes, raising the question, Is the antidepressant literature now being reported more transparently? What did the researchers do and find? ➢ Using FDA reviews on 4 newer antidepressants, we identified 30 trials, half with positive, and half with negative, outcomes. ➢ Among the 15 negative trials, 6 were unpublished and 2 others were misre ....
Ahead of the potential third wave of COVID-19, the Ahmedabad administration has taken up surveillance work and is conducting a pediatric survey to identify the most vulnerable children in order to make timely arrangements for their protection. Speaking to ANI, Health Officer Sandhya Rathod said, We have started screening children in the age group of 0-5 years. We have 206 teams of ASHA and Anganwadi workers. They are surveying around 250 houses per day. We are maintaining a separate list of children suffering from malnutrition and other severe diseases. In the case of the third wave, we can reverse quarantine the high-risk group. I have five teams in Sanand with two doctors and a female health worker in each team, she said. ....
AIIMS Delhi is going to start screening children for clinical trials of Covaxin from Monday. The Drugs Controller General of India (DCGI) gave nod to Bharat Biotech to conduct clinical trials on children on May 11. ....
Amid growing concern for when children will be vaccinated against coronavirus, the approval of Bharat Biotech s Covaxin for clinical trials on children above the age of. ....
India News: Bharath Biotech may start clinical trials of its Covid-19 vaccine Covaxin on children from June, a senior official of the vaccine-maker has said. The ....